betaxolol [Adjuvant]

Download Sequences


Accession ARO:3007750
DefinitionBetaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and angina, with a 50% inhibitory concentration (IC50) of 19.3 plus or minus 0.9 uM significantly inhibiting the hydrolytic activity of the NDM-1 enzyme and may represent a potential NDM-1 enzyme inhibitor. BET combined with meropenem (MEM) showed bactericidal synergism in vitro. BET inhibited NDM-1 by competitively binding to it and that it can be developed in combination with MEM as a new therapy.
SMILESCC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
PubChem2369
ChEMBLCHEMBL423
ChEBI3082
CAS63659-18-7
Classification5 ontology terms | Show
Parent Term(s)1 ontology terms | Show
Publications

Sun J, et al. 2023. Int J Mol Sci 24(17): Betaxolol as a Potent Inhibitor of NDM-1-Positive E. coli That Synergistically Enhances the Anti-Inflammatory Effect in Combination with Meropenem. (PMID 37686201)

Curator Acknowledgements
Curator Description Most Recent Edit